Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous dexosomes loaded with tumor-specific peptides (1 trial)
Melanoma (Phase 2)
Trials (1 total)
Trial APIs (1 total)